Register entry
CMP DEVELOPMENT LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 35
- Countries
- 0
Exclusivity
Patents and exclusivities
35| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10493083 | CAROSPIRspironolactone | product | Oct 2036 |
| 10624906 | CAROSPIRspironolactone | product | Oct 2036 |
| 10660907 | CAROSPIRspironolactone | product | Oct 2036 |
| 10888570 | CAROSPIRspironolactone | product | Oct 2036 |
| 11389461 | CAROSPIRspironolactone | product | Oct 2036 |
| 11395828 | CAROSPIRspironolactone | use | Oct 2036 |
| 11491166 | CAROSPIRspironolactone | product | Oct 2036 |
| 9757394 | CAROSPIRspironolactone | product | Oct 2036 |
| 11369567 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 11654106 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 11925704 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 12168069 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 12370136 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 12599553 | ATORVALIQatorvastatin calcium | product | Jun 2037 |
| 11337979 | LIQREVsildenafil citrate | product | Dec 2038 |
| 11382917 | TADLIQtadalafil | product | Dec 2038 |
| 11464778 | LIQREVsildenafil citrate | product | Dec 2038 |
| 11666576 | TADLIQtadalafil | product | Dec 2038 |
| 11759468 | LIQREVsildenafil citrate | product | Dec 2038 |
| 11975006 | TADLIQtadalafil | product | Dec 2038 |
| 12005062 | LIQREVsildenafil citrate | product | Dec 2038 |
| 12186321 | LIQREVsildenafil citrate | product | Dec 2038 |
| 12186322 | TADLIQtadalafil | product | Dec 2038 |
| 12691120 | TADLIQtadalafil | product | Dec 2038 |
| 12697338 | TADLIQtadalafil | product | Dec 2038 |
| 12708626 | TADLIQtadalafil | product | Dec 2038 |
| 12721849 | TADLIQtadalafil | product | Dec 2038 |
| 10632150 | POTASSIUM PHOSPHATESpotassium phosphate, dibasic; potassium phosphate, monobasic | product | Apr 2039 |
| 11253474 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 11458095 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 11723866 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 12005141 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 12226528 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 12440441 | NORLIQVAamlodipine besylate | product | Feb 2041 |
| 12551466 | QLONILIKclonidine hydrochloride | product | Aug 2045 |
Enquiry
Common questions
- Is CMP DEVELOPMENT LLC FDA approved?
- CMP DEVELOPMENT LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.